Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jaap Verweij

Showing results (21-30 of 234) with videos related to

Pageof 24
Sort By:
Clinical Advances in Hematology & Oncology : H&O|October 18, 2005
Highlights from the EORTC-NCI-AACR 2002 meeting: molecular targets and cancer therapeuticsEdward Sausville, Jaap Verweij
Expert Opinion on Pharmacotherapy|March 16, 2013
Pazopanib, a new therapy for metastatic soft tissue sarcomaJaap Verweij, Stefan Sleijfer
European Journal of Cancer (Oxford, England : 1990)|February 15, 2008
QTc prolongation and/or oncology drug development: who's in danger?Maja de Jonge, Jaap Verweij
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 15, 2007
Multitarget tyrosine kinase inhibition: [and the winner is...]Jaap Verweij, Maja de Jonge
Molecular Cancer Therapeutics|March 16, 2005
Imatinib and gastrointestinal stromal tumors: Where do we go from here?Ugo De Giorgi, Jaap Verweij
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 23, 2005
The epothilone dilemmaMaja de Jonge, Jaap Verweij
European Journal of Cancer (Oxford, England : 1990)|February 9, 2010
Future treatment of soft tissue sarcomas will be driven by histological subtype and molecular aberrationsJaap Verweij, Laurence H Baker
European Journal of Cancer (Oxford, England : 1990)|May 25, 2005
Docetaxel administration schedule: from fever to tears? A review of randomised studiesFrederike K Engels, Jaap Verweij
The Alkaloids. Chemistry and Biology|November 5, 2003
Clinical studies of camptothecin and derivativesOtto Soepenberg, Alex Sparreboom, Jaap Verweij
Expert Review of Anticancer Therapy|December 23, 2003
Role of imatinib mesylate (Gleevec/Glivec) in gastrointestinal stromal tumorsFloris A de Jong, Jaap Verweij
Pageof 24

Showing results (21-30 of 234) with videos related to

Sort By:
Pageof 24
Clinical Advances in Hematology & Oncology : H&O|October 18, 2005
Highlights from the EORTC-NCI-AACR 2002 meeting: molecular targets and cancer therapeuticsEdward Sausville, Jaap Verweij
Expert Opinion on Pharmacotherapy|March 16, 2013
Pazopanib, a new therapy for metastatic soft tissue sarcomaJaap Verweij, Stefan Sleijfer
European Journal of Cancer (Oxford, England : 1990)|February 15, 2008
QTc prolongation and/or oncology drug development: who's in danger?Maja de Jonge, Jaap Verweij
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 15, 2007
Multitarget tyrosine kinase inhibition: [and the winner is...]Jaap Verweij, Maja de Jonge
Molecular Cancer Therapeutics|March 16, 2005
Imatinib and gastrointestinal stromal tumors: Where do we go from here?Ugo De Giorgi, Jaap Verweij
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 23, 2005
The epothilone dilemmaMaja de Jonge, Jaap Verweij
European Journal of Cancer (Oxford, England : 1990)|February 9, 2010
Future treatment of soft tissue sarcomas will be driven by histological subtype and molecular aberrationsJaap Verweij, Laurence H Baker
European Journal of Cancer (Oxford, England : 1990)|May 25, 2005
Docetaxel administration schedule: from fever to tears? A review of randomised studiesFrederike K Engels, Jaap Verweij
The Alkaloids. Chemistry and Biology|November 5, 2003
Clinical studies of camptothecin and derivativesOtto Soepenberg, Alex Sparreboom, Jaap Verweij
Expert Review of Anticancer Therapy|December 23, 2003
Role of imatinib mesylate (Gleevec/Glivec) in gastrointestinal stromal tumorsFloris A de Jong, Jaap Verweij
Pageof 24